CDK1 and prostate carcinoma: In this study, we discovered the mechanism of ABCC5 in tumor development, namely, promoting malignant phenotypes such as proliferation and migration of prostate cancer by stabilizing CDK1 protein levels and activating ERK signaling pathways.